Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Zinc finger protein 277 is an intestinal transit-amplifying cell marker and colon cancer oncogene
Guofeng Xie, … , Harris Yfantis, Jean-Pierre Raufman
Guofeng Xie, … , Harris Yfantis, Jean-Pierre Raufman
Published January 11, 2022
Citation Information: JCI Insight. 2022;7(4):e150894. https://doi.org/10.1172/jci.insight.150894.
View: Text | PDF
Research Article Gastroenterology Oncology

Zinc finger protein 277 is an intestinal transit-amplifying cell marker and colon cancer oncogene

  • Text
  • PDF
Abstract

Sustained proliferative signaling and resisting cell death are hallmarks of cancer. Zinc finger protein 277 (ZNF277; murine Zfp277), a transcription factor regulating cellular senescence, is overexpressed in colon cancer, but its actions in intestinal homeostasis and neoplasia are unclear. Using human and murine intestine, human colon cancer cells, and ApcMin/+ mice with dysregulated β-catenin signaling and exuberant intestinal neoplasia, we explored the actions of ZNF277/Zfp277 and defined the underlying mechanisms. In normal human and murine intestine, ZNF277/Zfp277 was expressed uniquely in early stem cell progenitors, undifferentiated transit-amplifying cells (TACs). Zfp277 was overexpressed in the ApcMin/+ mouse colon, implicating ZNF277/Zfp277 as a transcriptional target of β-catenin signaling. We confirmed this by showing β-catenin knockdown reduced ZNF277 expression and, using chromatin IP, identified 2 β-catenin binding sites in the ZNF277 promoter. Zfp277 deficiency attenuated intestinal epithelial cell proliferation and tumor formation, and it strikingly prolonged ApcMin/+ mouse survival. RNA-Seq and PCR analyses revealed that Zfp277 modulates expression of genes in key cancer pathways, including β-catenin signaling, the HOXD family that regulates development, and p21WAF1, a cell cycle inhibitor and tumor suppressor. In both human colon cancer cells and the murine colon, ZNF277/Zfp277 deficiency induced p21WAF1 expression and promoted senescence. Our findings identify ZNF277/Zfp277 as both a TAC marker and colon cancer oncogene that regulates cellular proliferation and senescence, in part by repressing p21WAF1 expression.

Authors

Guofeng Xie, Zhongsheng Peng, Jinqing Liang, Shannon M. Larabee, Cinthia B. Drachenberg, Harris Yfantis, Jean-Pierre Raufman

×

Figure 7

ZNF277 deficiency augments p21WAF1 expression.

Options: View larger image (or click on image) Download as PowerPoint
ZNF277 deficiency augments p21WAF1 expression.
(A) siRNA and CRISPR knoc...
(A) siRNA and CRISPR knockdown of ZNF277 expression augments p21WAF1 levels in HT29, H508, and HEK293 cells. β-Actin was used as a loading control. (B) Levels of murine p21WAF1 expression are augmented in colon tissue extracts from ApcMin/+ and Zfp277–/– mice. Experiments were performed using tissues from 2 separate 8-week-old mice of each genotype. (C) Upregulated p21WAF1 expression after p53 and ZNF277 knockdown in HT29 cells. All siRNAs were 25 nM, except lane 4 (50 nM). (D) ZNF277 knockdown augments p21WAF1 mRNA levels in HT29 cells. Data are shown as mean ± SEM from 3 separate experiments. *P < 0.01 (2-tailed Student’s t test). (E) Zfp277 deficiency stimulates cellular senescence. β-Galactosidase staining in control HT29 cells (A) and HT29 cells with CRISPR knockdown of ZNF277 (B). Scale bar: 50 μM. (F) Zfp277 deficiency increases p21WAF1 expression. IHC of p21WAF1 in the normal small intestine of WT (A) and Zfp277–/– (B) mice, as well as in small intestine adenomas from Zfp277+/+ApcMin/+ (C) and Zfp277–/–ApcMin/+ (D) mice. Arrows indicate adenomas. Scale bar: 100 μM.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts